ETF Holdings Breakdown of IART

News associated with IART

Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from Analysts

Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy […] - 2025-06-17 05:49:03

Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH)

Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Volatility and Risk Arch Therapeutics has a […] - 2025-06-16 05:40:44

Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 71.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 25,285 shares of the life sciences company’s stock after selling 64,458 shares during the period. Squarepoint Ops LLC’s holdings in Integra LifeSciences were worth $573,000 as […] - 2025-06-04 08:48:48

75,900 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 75,900 shares of the life sciences company’s stock, valued at approximately $1,721,000. Other hedge funds and other institutional investors have also recently bought and sold […] - 2025-06-03 08:34:56

BNP Paribas Financial Markets Has $333,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)

BNP Paribas Financial Markets cut its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,690 shares of the life sciences company’s stock after selling 97,085 shares during the period. BNP Paribas Financial […] - 2025-05-27 09:12:44

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,437 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 38,466 shares of the life sciences company’s stock after buying an additional 1,437 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS […] - 2025-05-27 07:47:03

Financial Review: Integra LifeSciences (NASDAQ:IART) and Vivos (OTCMKTS:RDGL)

Integra LifeSciences (NASDAQ:IART – Get Free Report) and Vivos (OTCMKTS:RDGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Integra LifeSciences and Vivos’ […] - 2025-05-26 05:20:55

Brokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $18.63

Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been given an average recommendation of “Reduce” by the nine analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy […] - 2025-05-23 05:48:54

Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low Following Weak Earnings

Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $11.60 and last traded at $13.28, with a volume of 7492449 shares trading hands. The stock had previously closed […] - 2025-05-07 06:10:42

Head to Head Review: Integra LifeSciences (NASDAQ:IART) & Venus Concept (NASDAQ:VERO)

Venus Concept (NASDAQ:VERO – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […] - 2025-05-06 05:46:55

Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings

Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) gapped down before the market opened on Monday following a dissappointing earnings announcement. The stock had previously closed at $16.85, but opened at $14.73. Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 […] - 2025-05-06 05:10:50

Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $22.71 Consensus PT from Analysts

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has earned an average recommendation of “Reduce” from the nine ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the […] - 2025-04-28 05:24:43

Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Sterling Capital Management LLC

Sterling Capital Management LLC boosted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 821.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,166 shares of the life sciences company’s stock after purchasing an additional 1,931 shares during the period. Sterling Capital Management LLC’s […] - 2025-04-24 08:46:54

Legal & General Group Plc Has $4.91 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)

Legal & General Group Plc lessened its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 216,507 shares of the life sciences company’s stock after selling 16,109 shares during the quarter. Legal & […] - 2025-04-22 07:44:49

Sei Investments Co. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)

Sei Investments Co. trimmed its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,953 shares of the life sciences company’s stock after selling 4,448 shares during the period. Sei Investments Co.’s holdings in Integra LifeSciences were worth $430,000 at the […] - 2025-04-10 07:24:49

Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,580,967 shares of the life sciences company’s stock after selling 162,961 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Integra LifeSciences worth $171,936,000 at […] - 2025-04-07 07:41:00

Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus

Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […] - 2025-04-02 06:12:48

Quantbot Technologies LP Has $179,000 Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)

Quantbot Technologies LP lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 89.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,881 shares of the life sciences company’s stock after selling 64,470 shares during the period. Quantbot Technologies LP’s holdings in Integra LifeSciences were worth $179,000 at the end of […] - 2025-03-31 07:39:00

Intech Investment Management LLC Acquires 11,174 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)

Intech Investment Management LLC raised its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,113 shares of the life sciences company’s stock after acquiring an additional 11,174 shares during the period. Intech Investment Management LLC’s holdings in Integra LifeSciences were worth […] - 2025-03-25 09:08:55

PNC Financial Services Group Inc. Grows Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)

PNC Financial Services Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,755 shares of the life sciences company’s stock after purchasing an additional […] - 2025-03-20 07:57:04

Integra LifeSciences Holdings Co. (NASDAQ:IART) Holdings Lowered by Bank of New York Mellon Corp

Bank of New York Mellon Corp cut its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,962 shares of the life sciences company’s stock after selling 15,830 shares […] - 2025-03-14 07:05:06

Amalgamated Bank Sells 478 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)

Amalgamated Bank reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,394 shares of the life sciences company’s stock after selling 478 shares during the quarter. Amalgamated Bank’s holdings […] - 2025-03-05 10:26:53

Yousif Capital Management LLC Sells 906 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)

Yousif Capital Management LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The firm owned 25,762 shares of the life sciences company’s stock after selling 906 shares during the quarter. Yousif Capital Management LLC’s holdings in Integra LifeSciences were worth $584,000 […] - 2025-02-17 08:42:58

IART institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	44,849	USD 547,606
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	46,757	USD 570,903
2025-06-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	84,469	USD 1,031,366
2025-06-26	IE00BMX0DF60 (iShares US Medical Devices UCITS ETF)	9,367	USD 114,371
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	2,726	USD 33,284
Total =		188,168	USD 2,297,530

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer